Superseded · version 1: Petrelintide^↗

Related names recorded in this version: ZP8396^↗

An amylin analogue candidate represented in ClinicalTrials.gov.^↗

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

ClinicalTrials.gov lists a Roche-sponsored combination study as not yet recruiting, updated July 7, 2026.^↗

Organizations named in cited records:

Trial records: NCT07589686